Journal
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY
Volume 51, Issue 1, Pages 618-629Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/21691401.2023.2274047
Keywords
Gynaecological cancers; lab-on-a-chip (LoC); cancer screening; cancer diagnosis; microfluidics
Ask authors/readers for more resources
Gynaecological cancers pose a major global health concern, with inadequate screening and diagnostic methods for ovarian, endometrial, and cervical cancer. Portable and cost-effective lab-on-a-chip (LoC) technologies show promise for mass screening and diagnosis of gynaecological cancers. However, further research and validation are needed before widespread adoption in clinical practice.
Gynaecological cancers are a major global health concern due to the lack of effective screening programmes for ovarian and endometrial cancer, for example, and variable access to vaccination and screening tests for cervical cancer in many countries. Recent research on portable and cost-effective lab-on-a-chip (LoC) technologies show promise for mass screening and diagnostic procedures for gynaecological cancers. However, most LoCs for gynaecological cancer are still in development, with a need to establish and clinically validate factors such as the type of biomarker, sample and method of detection, before patient use. Multiplex approaches, detecting a panel of gynaecological biomarkers in a single LoC, offer potential for more reliable diagnosis. This review highlights the current research on LoCs for gynaecological cancer screening and diagnosis, emphasizing the need for further research and validation prior to their widespread adoption in clinical practice.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available